S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
Log in

NASDAQ:ARWRArrowhead Pharmaceuticals SEC Filings & 10K Form

$29.78
+0.84 (+2.90 %)
(As of 04/7/2020 02:06 PM ET)
Add
Compare
Today's Range
$28.65
Now: $29.78
$30.50
50-Day Range
$20.56
MA: $31.30
$41.27
52-Week Range
$17.30
Now: $29.78
$73.72
Volume904,776 shs
Average Volume1.98 million shs
Market Capitalization$3.03 billion
P/E Ratio56.19
Dividend YieldN/A
Beta1.94

SEC Filings

Arrowhead Pharmaceuticals (NASDAQ:ARWR) SEC Filings

DateFilerForm TypeView
03/19/2020
4:18 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2020
1:47 PM
Arrowhead Pharmaceuticals (Subject)
FIRST MANHATTAN CO (Filed by)
Form SC 13G/A
01/28/2020
3:31 PM
Arrowhead Pharmaceuticals (Filer)
Form DEF 14A
01/23/2020
5:15 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:00 PM
Arrowhead Pharmaceuticals (Filer)
Form PRE 14A
01/13/2020
4:13 PM
Arrowhead Pharmaceuticals (Issuer)
Hassard James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2020
5:35 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:33 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:31 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:10 PM
Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:08 PM
Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:06 PM
Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:04 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:02 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
3:54 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
3:51 PM
Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2019
5:35 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
8:55 PM
Arrowhead Pharmaceuticals (Filer)
Form 424B5
12/04/2019
5:48 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:48 PM
Arrowhead Pharmaceuticals (Filer)
Form 424B5
12/02/2019
3:02 PM
Arrowhead Pharmaceuticals (Filer)
Form S-3ASR
11/25/2019
3:11 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/25/2019
3:05 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
5:48 PM
Arrowhead Pharmaceuticals (Issuer)
Bradshaw Curt (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2019
5:44 PM
Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2019
5:45 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
6:32 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2019
6:31 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
9:56 AM
Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
09/27/2019
8:16 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
8:12 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
7:09 PM
Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
3:09 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
3:03 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
6:19 PM
Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
5:12 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
6:01 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
5:57 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
4:44 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:12 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2019
4:10 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
5:57 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
3:55 PM
Arrowhead Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2019
2:17 PM
Arrowhead Pharmaceuticals (Filer)
Form CT ORDER
03/15/2019
4:09 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
7:42 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
6:08 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:32 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
7:12 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
7:09 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
8:22 AM
Arrowhead Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2019
2:29 PM
Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/12/2019
7:58 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
7:35 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:50 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/07/2019
3:26 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2019
6:51 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:00 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2019
3:16 PM
Arrowhead Pharmaceuticals (Filer)
Form DEFA14A
01/25/2019
3:11 PM
Arrowhead Pharmaceuticals (Filer)
Form DEF 14A
01/24/2019
7:53 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
7:46 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
6:02 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
6:00 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
7:24 PM
Arrowhead Pharmaceuticals (Issuer)
Li Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
7:18 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
2:12 PM
Arrowhead Pharmaceuticals (Subject)
OppenheimerFunds, Inc. (Filed by)
Form SC 13G/A
01/11/2019
5:15 PM
Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
4:12 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
7:18 PM
Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:16 PM
Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:15 PM
Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:13 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:08 PM
Arrowhead Pharmaceuticals (Issuer)
Li Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
6:58 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
6:55 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
6:53 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
6:49 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
4:20 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:15 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2018
6:40 PM
Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
4:18 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
3:11 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/11/2018
3:05 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2018
4:20 PM
Arrowhead Pharmaceuticals (Filer)
Form S-3ASR
11/26/2018
8:09 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
6:01 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2018
7:06 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2018
6:59 PM
Arrowhead Pharmaceuticals (Issuer)
Leone Peter Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2018
8:16 AM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2018
5:32 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
3:23 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
8:18 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2018
4:34 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
8:17 AM
Arrowhead Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
05/08/2018
3:11 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2018
6:40 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
6:46 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2018
5:09 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
5:58 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel